Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Pulike Biological Engineering's Days Inventory or its related term are showing as below:
SHSE:603566'
s Days Inventory Range Over the Past 10 Years
Min: 133.08 Med: 145.27 Max: 172.06
Current: 167.01
During the past 13 years, Pulike Biological Engineering's highest Days Inventory was 172.06. The lowest was 133.08. And the median was 145.27.
SHSE:603566's Days Inventory is ranked better than 53.92% of 638
companies
in the Biotechnology industry
Industry Median: 181.695
vs SHSE:603566: 167.01
Inventory Turnover measures how fast the company turns over its inventory within a year.
Pulike Biological Engineering's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.50.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pulike Biological Engineering's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 0.90.
Pulike Biological Engineering (SHSE:603566) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Pulike Biological Engineering's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Pulike Biological Engineering's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Pulike Biological Engineering Days Inventory Related Terms
Pulike Biological Engineering Days Inventory Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulike Biological Engineering Days Inventory Chart
SHSE:603566 vs VRTX, REGN, RVMD: Days Inventory Comparison
For the Biotechnology subindustry, Pulike Biological Engineering's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pulike Biological Engineering Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Pulike Biological Engineering's Days Inventory distribution charts can be found below:
* The bar in red indicates where Pulike Biological Engineering's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pulike Biological Engineering (SHSE:603566) has a Days Inventory of 182.62 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pulike Biological Engineering and its competitors. This is 26% above median its historical median of 145.27. Over the past decade, Pulike Biological Engineering's Days Inventory has ranged from 133.08 to 172.06. According to the industry distribution chart, Pulike Biological Engineering ranks #294 out of 638 companies in the Biotechnology industry, placing it in the top 46.1%.
Is Pulike Biological Engineering's Days Inventory too high?
Pulike Biological Engineering's current Days Inventory of 182.62 is 26% above median its 10-year median of 145.27. Over the past 10 years, this metric has ranged from a low of 133.08 to a high of 172.06. The Biotechnology industry median Days Inventory is 181.70. Pulike Biological Engineering's value of 182.62 is 0.5% above this industry median. Based on the distribution chart, Pulike Biological Engineering ranks #294 out of 638 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Pulike Biological Engineering has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pulike Biological Engineering's Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Pulike Biological Engineering ranks #294 out of 638 companies for Days Inventory. This puts Pulike Biological Engineering in the upper half of its industry. The industry median Days Inventory is 181.70. Pulike Biological Engineering's value of 182.62 is 0.5% above this benchmark. Historically, Pulike Biological Engineering's own Days Inventory has ranged from 133.08 to 172.06 over the past decade. While the company's 10-year median is 145.27 vs. the industry median of 181.70, Pulike Biological Engineering has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 181.70, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Pulike Biological Engineering's current Days Inventory of 182.62 is 0.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Pulike Biological Engineering and its competitors. For the Biotechnology industry, the median Days Inventory is 181.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pulike Biological Engineering's current Days Inventory is 182.62, which is 26% above median its own 10-year median of 145.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulike Biological Engineering stock overvalued right now?
Based on GuruFocus' analysis, Pulike Biological Engineering (SHSE:603566) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.41, compared to a current price of ¥10.29 — trading 28.6% below its estimated fair value. The current Days Inventory is 182.62, which is 26% above median its 10-year median of 145.27 and 0.5% above the Biotechnology industry median of 181.70. Pulike Biological Engineering's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Pulike Biological Engineering (SHSE:603566), the current Days Inventory is 182.62 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Pulike Biological Engineering (SHSE:603566) Overvalued in 2026?
Based on GuruFocus' analysis, Pulike Biological Engineering stock appears to be undervalued.
The current stock price of ¥10.29 is trading 28.6% below its estimated GF Value™ of ¥14.41.
GuruFocus considers Pulike Biological Engineering to be Modestly Undervalued.
Key valuation signals for SHSE:603566:
Days Inventory: 182.62 (26% above median its 10-year median of 145.27)
GF Value™: ¥14.41 vs. price of ¥10.29 (28.6% below fair value)
Industry Position: 0.5% above the Biotechnology median (#294 of 638)
No single metric tells the full story. See the SHSE:603566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603566 has been successfully added to your 
